Article info
Pancreas
Original article
Lysine methyltransferase 2D regulates pancreatic carcinogenesis through metabolic reprogramming
- Correspondence to Dr Dimitrios Iliopoulos, Center for Systems Biomedicine, Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, UCLA, Los Angeles 90095, USA; iliopoulospharma{at}gmail.com
Citation
Lysine methyltransferase 2D regulates pancreatic carcinogenesis through metabolic reprogramming
Publication history
- Received November 15, 2017
- Revised September 6, 2018
- Accepted September 12, 2018
- First published October 18, 2018.
Online issue publication
August 21, 2019
Article Versions
- Previous version (7 June 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.